Clinical trial
The Framingham Study: Examining DNA Markers and Links to Diseases
NCT00062777 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00062777 |
|---|---|
| Title | The Framingham Study: Examining DNA Markers and Links to Diseases |
| Official title | A Genome-Wide Scan for Quantitative Trait Loci of Hematocrit - A Framingham Study |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Vascular Diseases |
| Enrollment | 330 |
| Start date | Jun 12, 2003 |
| Completion | Jun 16, 2011 |
| First posted | Jun 16, 2003 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: